Short Interest in Poxel S.A. (OTCMKTS:PXXLF) Declines By 95.0%

Poxel S.A. (OTCMKTS:PXXLF) saw a significant decrease in short interest during the month of August. As of August 31st, there was short interest totalling 100 shares, a decrease of 95.0% from the August 15th total of 2,000 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Poxel Price Performance

OTCMKTS PXXLF remained flat at $0.70 during trading hours on Thursday. Poxel has a fifty-two week low of $0.55 and a fifty-two week high of $0.70. The stock has a fifty day simple moving average of $0.70 and a 200 day simple moving average of $0.66.

About Poxel

Poxel SA, a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan.